Symbiotec Pharmalab to Open IPO for Subscription on August 24, 2026
Symbiotec Pharmalab will open its IPO for subscription from August 24–27, 2026, with a price band of INR 938–INR 988 per share and an OFS component of up to INR 1,607 crore.
Initial Public Offering | 20/08/2026 | By News Bureau
Agomab Unveils Plans for Initial Public Offering
Agomab has appointed JP Morgan, Morgan Stanley, Leerink Partners and Van Lanschot Kempen as joint book-running managers for the proposed Initial Public Offering (IPO), marking a key step in its plans to access the public markets.
Initial Public Offering | 03/02/2026 | By News Bureau | 205
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy